Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

The aberrant hemostasis is a common manifestation of cancer, and venous
thromboembolism (VTE) is the second leading cause of cancer patients' mortality. Tissue …

Purpose Without a standard test for pancreatic carcinomas, this highly lethal disease is
normally diagnosed at its advanced stage, leading to a low survival rate of patients …

Development of novel imaging probes for cancer diagnostics remains critical for early
detection of disease, yet most imaging agents are hindered by suboptimal tumor …

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. To improve outcomes,
there is a critical need for improved tools for detection, accurate staging, and resectability …

Tissue factor (TF) is a protein that plays a critical role in blood clotting, but recent research
has also shown its involvement in cancer development and progression. Herein, we provide …

Anaplastic thyroid cancer (ATC) is the most aggressive subtype of thyroid cancers with a
dismal prognosis. It is aimed to explore a new biomarker and devise a marker‐dependent …

Simple Summary Microparticles (MPs) play a key role in intercellular communication and
mediate many features of cancers by delivering their various biomolecular cargos (including …

Pancreatic cancer is highly aggressive, with a median survival time of less than 6 months
and a 5-year overall survival rate of around 7%. The poor prognosis of PaCa is largely due …

Simple Summary Patients diagnosed with pancreatic cancer have a poor prognosis at time
of diagnosis, with a 5-year survival rate of merely 10%. The only treatment with curative …